Pelthos Therapeutics Inc

Biotech Stocks Healthcare Stocks

$28.26

+0.71 (+2.58%)

As of Jun 30, 10:36 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 12 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target -3.5% upside

Low Target $18.57

Average Target $27.28

High Target $35.01

Current Price $28.26

Current
$28.26

Target
$27.28

$18.57 $27.28 avg $35.01

Scenario Analysis

Bear Case

$18.57

-34.3%

Low target

Base Case

$27.28

-3.5%

Avg target

Bull Case

$35.01

+23.9%

High target

Risk/Reward

0.7x

Unfavorable

Price in Context

52-Week High

$54.29

-47.9% from high

52-Week Low

$11.20

+152.3% from low

Target vs 52W High

$27.28

-49.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%